Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Rotate Tesamorelin Injection Sites: Clinical vs Real-World Comparison

Four-Zone Daily Rotation (Clinical Standard) 72 hours per site <5% over 24 weeks High. Minimal variability in Cmax Gold standard for long-term protocols; prevents tissue damage through adequate recovery intervals Two-Zone Alternating (Common Error) 24 hours pe

This comparison does not assign a generated winner or score.

  • Four-Zone Daily Rotation (Clinical Standard)
  • 72 hours per site
  • <5% over 24 weeks
  • High. Minimal variability in Cmax
  • Gold standard for long-term protocols; prevents tissue damage through adequate recovery intervals
  • Two-Zone Alternating (Common Error)
  • 24 hours per site
  • 35–50% by week 12
  • Moderate. Declining over time as nodules form
  • Insufficient recovery time; tissue stress accumulates faster than resolution
  • Random Abdominal Rotation Without Spacing
  • Variable. Often <48 hours
  • 40–60% by week 8
  • Low. Overlapping trauma zones reduce bioavailability
  • Fails to prevent localized damage; spacing violations negate rotation benefits
  • Same-Site Daily Injection (Treatment Failure Pattern)
  • 0 hours. Continuous trauma
  • >80% by week 6
  • Very low. Nodules reduce absorption 20–30%
  • Guaranteed lipohypertrophy; treatment outcomes compromised within two months
More references

Related material